Published in Radiologe on December 01, 2000
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med (2000) 2.86
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg (2010) 2.52
Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther (2001) 2.51
Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study. Circulation (2000) 1.59
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol (2003) 1.44
Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology (1995) 1.43
Evidence of carotid atherosclerosis in orthopantomograms and the risk for future cardiovascular events. Vasa (2010) 1.43
The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost (2003) 1.42
Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients. Ann Hematol (2003) 1.39
Changes in perinatal cocaine use in an inner-city hospital, 1988 to 1992. Am J Public Health (1995) 1.38
Femoropopliteal artery: initial and 6-month results of color duplex US-guided percutaneous transluminal angioplasty. Radiology (1996) 1.37
Effect of high water fluoride concentration on the intellectual development of children in makoo/iran. J Dent (Tehran) (2012) 1.18
Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. J Clin Endocrinol Metab (1990) 1.13
The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost (2005) 1.12
Antiplatelet treatment prolongs survival after carotid bifurcation endarterectomy. Analysis of the clinical series followed by a controlled trial. Ann Surg (1990) 1.12
Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg (1994) 1.11
Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med (1988) 1.06
PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol (2006) 1.05
Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother (1999) 1.04
Risk stratification for subclavian artery angioplasty: is there an increased rate of restenosis after stent implantation? J Endovasc Ther (2001) 1.01
Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. Eur J Clin Invest (2005) 0.99
The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thromb Haemost (1997) 0.95
Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. Clin Pharmacol Ther (2001) 0.93
Critical care management of potential organ donors: our current standard. Clin Transplant (2009) 0.92
Effects of oat and wheat cereals on endothelial responses. Prev Med (2001) 0.92
Pyridoxine therapy in patients with renal calcium oxalate calculi. Proc Eur Dial Transplant Assoc (1983) 0.91
Deep venous thrombosis of the lower extremity: efficacy of spiral CT venography compared with conventional venography in diagnosis. Radiology (1996) 0.90
Endovascular AAA treatment: expensive prestige or economic alternative? Eur J Vasc Endovasc Surg (1997) 0.89
Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation. J Endovasc Ther (2001) 0.89
Long-term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12-year retrospective patient analysis. Scand J Rheumatol (2003) 0.89
Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation. J Neurooncol (2005) 0.87
Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res (2001) 0.86
Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery. Lancet (1988) 0.86
Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. Thromb Res (1990) 0.86
The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene. Thromb Haemost (1999) 0.86
Neuropsychological outcome 6 months after unilateral carotid stenting. J Clin Exp Neuropsychol (2005) 0.85
Carotid artery stenting: effect of learning curve and intermediate-term morphological outcome. J Endovasc Ther (2001) 0.85
C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism. Atherosclerosis (2005) 0.85
Predictors of long-term results after treatment of iliac artery obliteration by transluminal angioplasty and stent deployment. Cardiovasc Intervent Radiol (2002) 0.84
Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients. Platelets (2002) 0.84
Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: a preliminary report. J Vasc Surg (1987) 0.84
Fibrinogen predicts mortality in high risk patients with peripheral artery disease. Eur J Vasc Endovasc Surg (2003) 0.83
Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke (1989) 0.83
Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE .035 peripheral self-expanding stent system for occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS Trial): acute and 30-day results. J Cardiovasc Surg (Torino) (2007) 0.83
Tissue concentration of clindamycin and gentamicin near ischaemic ulcers with transvenous injection in Bier's arterial arrest. Lancet (1996) 0.83
Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. Eur J Clin Invest (2009) 0.83
[Recurrence of spontaneous kidney rupture in a dialysis patient]. Schweiz Med Wochenschr (1982) 0.82
Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease. Eur J Clin Invest (2007) 0.82
Acute effects of oats and vitamin E on endothelial responses to ingested fat. Am J Prev Med (2001) 0.82
Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin. Thromb Haemost (1989) 0.81
Value of negative spiral CT angiography in patients with suspected acute PE: analysis of PE occurrence and outcome. Eur Radiol (2003) 0.81
Homocysteine levels in patients with Raynaud's phenomenon. Vasa (2002) 0.80
Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients. Diabet Med (2002) 0.80
Prospective clinical study with in vitro endothelial cell lining of expanded polytetrafluoroethylene grafts in crural repeat reconstruction. J Vasc Surg (1992) 0.80
[Pseudonormalization of diffusion weighted images: magnetic resonance imaging in an animal model (C6-glioma)]. Rofo (2005) 0.80
Effect of lovastatin on hemorheology in type II hyperlipoproteinemia. Atherosclerosis (1990) 0.80
Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? Atherosclerosis (1996) 0.80
[Randomized comparative study of the recurrence rate following femoro-popliteal PTA: high (1.0 g/die) vs low (0.1 g/die) acetylsalicylic acid dose]. Vasa Suppl (1991) 0.80
Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys (2000) 0.79
Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology (1998) 0.79
Outcome of conservative therapy of patients with severe intermittent claudication. Eur J Vasc Endovasc Surg (2004) 0.79
Influence of HMG-CoA-reductase inhibitors on the body fat status. Vasa (2006) 0.79
Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography. J Vasc Surg (1997) 0.79
Ultrasound with Levovist in the diagnosis of suspected calf vein thrombosis. Ultrasound Med Biol (2001) 0.79
Reduction in renal function after renal arteriography and after renal artery angioplasty. Eur J Vasc Endovasc Surg (2002) 0.79
Oro-dental health status and salivary characteristics in children with chronic renal failure. J Dent (Tehran) (2011) 0.79
Low level laser therapy for treatment of primary and secondary Raynaud's phenomenon. Vasa (2004) 0.78
Molecular cloning of gluconobacter oxydans DSM 2003 xylitol dehydrogenase gene. Res Pharm Sci (2011) 0.78
The first 15 months of transluminal abdominal aortic aneurysm management: a single centre experience. Eur J Vasc Endovasc Surg (1997) 0.78
D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb Haemost (1990) 0.78
Multicentre evaluation of a new point-of-care test for the quantitative determination of D-dimer. Clin Chim Acta (2001) 0.78
[Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities]. Wien Klin Wochenschr (1986) 0.77
Deep vein thrombosis: scintigraphic diagnosis with In-111-labeled monoclonal antifibrin antibodies. Radiology (1989) 0.77
[Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function]. Wien Klin Wochenschr (1985) 0.77
No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest (2006) 0.77
Results of a new rapid d-dimer assay (cardiac d-dimer) in the diagnosis of deep vein thrombosis. Thromb Res (2001) 0.77
Spontaneous laser doppler flux distribution in ischemic ulcers and the effect of prostanoids: a crossover study comparing the acute action of prostaglandin E1 and iloprost vs saline. Microvasc Res (1996) 0.77
Endovascular stent implantation for treatment of peripheral artery disease. Eur J Clin Invest (2007) 0.77
Endovascular management of "endoleaks" after transluminal infrarenal abdominal aneurysm repair. Eur J Vasc Endovasc Surg (1998) 0.77
Plaque imaging of the internal carotid artery - correlation of B-flow imaging with histopathology. AJNR Am J Neuroradiol (2007) 0.77
Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy. Thromb Haemost (1987) 0.77
Double-chimera proteins to enhance recruitment of endothelial cells and their progenitor cells. Int J Cardiol (2012) 0.77
Experimental monitoring of hepatic glucose, lactate, and glutamate metabolism by microdialysis during surgical preparation of the liver hilus. J Surg Res (2002) 0.76
Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy. Neuropsychobiology (1984) 0.76
Predicting renal failure after balloon angioplasty in high-risk patients. J Endovasc Ther (2001) 0.76
Low level laser treatment of primary and secondary Raynaud's phenomenon. Vasa (2001) 0.76
Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology (2001) 0.76